Novartis (NVS) PT Raised to $100 at Leerink Partners
Tweet Send to a Friend
Leerink Partners raised its price target on Novartis (NYSE: NVS) to $100.00 (from $93.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
